AMS – HM – Infectious Diseases: Meningitis; Multi-Drug Resistant Infections; Newer Antibacterial Agents

$119.00$189.00

$189.00
$119.00
StreamingINCLUDED FREE

Topics and Objectives

Title: Hospital Medicine – Infectious Diseases: Meningitis; Multi-Drug Resistant Infections; Newer Antibacterial Agents

Faculty: Stephen J. Gluckman, M.D., Janet M. Hines, M.D., Keith S. Kaye, M.D.

Original Release Date: July 1, 2018  Expiration Date: July 1, 2021

TOPIC 1: Meningitis: Commonly Asked Questions.

Upon completion of this session, the participants should be able to: GL, COMP

  1. Interpret normal CSF parameters.
  2. Interpret abnormal CSF findings and apply them to the proper management of patients.
  3. Relate an understanding of some of the more controversial clinical areas associated with the management of meningitis such as:
    1. The IDSA guidelines on the use of steroids;
    2. Who requires a CT scan prior to a lumbar puncture;
    3. The effect of prior antibiotic treatment on the interpretations of CSF.
  4. Discriminate the causes of aseptic meningitis with specific emphasis on the non-viral, treatable etiologies.

TOPIC 2: Multi-Drug Resistant Infections.

Upon completion of this session, the participant should be able to: EBM, COMP

  1. Asses to identify and avoid or minimize the urgent and serious threats of drug resistance as identified by the CDC and IDSA.
  2. Apply the most effective and appropriate treatment and strategy for each infection.
  3. Determine when specialist referral will result in an improved outcome

TOPIC 3: Newer Antibacterial Agents.

Upon completion of this session, using FDA publications and approvals as well as IDSA and SHEA evidence-based guidelines, the participant should be able to: EBM, GL, COMP

  1. Relate the antibacterial spectrum of activity and indications for use.
  2. Employ knowledge of the pharmacology of the agents.
  3. Appropriately prescribe the agents.
  4. Assess side effects, adverse reactions and drug interactions.

Total Cost: $

Title: Hospital Medicine – Infectious Diseases: Meningitis; Multi-Drug Resistant Infections; Newer Antibacterial Agents

Faculty: Stephen J. Gluckman, M.D., Janet M. Hines, M.D., Keith S. Kaye, M.D.

Original Release Date: July 1, 2018  Expiration Date: July 1, 2021

TOPIC 1: Meningitis: Commonly Asked Questions.

Upon completion of this session, the participants should be able to: GL, COMP

  1. Interpret normal CSF parameters.
  2. Interpret abnormal CSF findings and apply them to the proper management of patients.
  3. Relate an understanding of some of the more controversial clinical areas associated with the management of meningitis such as:
    1. The IDSA guidelines on the use of steroids;
    2. Who requires a CT scan prior to a lumbar puncture;
    3. The effect of prior antibiotic treatment on the interpretations of CSF.
  4. Discriminate the causes of aseptic meningitis with specific emphasis on the non-viral, treatable etiologies.

TOPIC 2: Multi-Drug Resistant Infections.

Upon completion of this session, the participant should be able to: EBM, COMP

  1. Asses to identify and avoid or minimize the urgent and serious threats of drug resistance as identified by the CDC and IDSA.
  2. Apply the most effective and appropriate treatment and strategy for each infection.
  3. Determine when specialist referral will result in an improved outcome

TOPIC 3: Newer Antibacterial Agents.

Upon completion of this session, using FDA publications and approvals as well as IDSA and SHEA evidence-based guidelines, the participant should be able to: EBM, GL, COMP

  1. Relate the antibacterial spectrum of activity and indications for use.
  2. Employ knowledge of the pharmacology of the agents.
  3. Appropriately prescribe the agents.
  4. Assess side effects, adverse reactions and drug interactions.

Additional information

Format

Hardcopy, Download